These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8911559)

  • 1. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy.
    Lauritzen L; Odgaard K; Clemmesen L; Lunde M; Ohrström J; Black C; Bech P
    Acta Psychiatr Scand; 1996 Oct; 94(4):241-51. PubMed ID: 8911559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
    Benkert O; Gründer G; Wetzel H; Hackett D
    J Psychiatr Res; 1996; 30(6):441-51. PubMed ID: 9023787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada.
    Lapierre Y; Bentkover J; Schainbaum S; Manners S
    Can J Psychiatry; 1995 Sep; 40(7):370-7. PubMed ID: 8548716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression.
    Le Noury J; Nardo JM; Healy D; Jureidini J; Raven M; Tufanaru C; Abi-Jaoude E
    Int J Risk Saf Med; 2016 Sep; 28(3):143-61. PubMed ID: 27662279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression.
    Claghorn JL; Feighner JP
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):23S-27S. PubMed ID: 8106652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.
    Benkert O; Szegedi A; Wetzel H; Staab HJ; Meister W; Philipp M
    Acta Psychiatr Scand; 1997 Apr; 95(4):288-96. PubMed ID: 9150822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2006 Feb; 67(2):263-8. PubMed ID: 16566622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia.
    Katona CL; Hunter BN; Bray J
    Int J Geriatr Psychiatry; 1998 Feb; 13(2):100-8. PubMed ID: 9526179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine.
    Naudon L; Hotte M; Jay TM
    Psychopharmacology (Berl); 2007 Apr; 191(2):353-64. PubMed ID: 17219219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.
    Le Noury J; Nardo JM; Healy D; Jureidini J; Raven M; Tufanaru C; Abi-Jaoude E
    BMJ; 2015 Sep; 351():h4320. PubMed ID: 26376805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study comparing paroxetine placebo and imipramine in depressed patients.
    Feighner JP; Cohn JB; Fabre LF; Fieve RR; Mendels J; Shrivastava RK; Dunbar GC
    J Affect Disord; 1993 Jun; 28(2):71-9. PubMed ID: 8354771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
    JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
    Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
    J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.
    Chiu HJ; Hong CJ; Chan CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):418-23. PubMed ID: 8803304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine.
    Janakiramaiah N; Gangadhar BN; Naga Venkatesha Murthy PJ; Harish MG; Subbakrishna DK; Vedamurthachar A
    J Affect Disord; 2000; 57(1-3):255-9. PubMed ID: 10708840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.